Tag Archives: Adipose tissue

Life Stem Genetics Announces Collaborative Agreement with American CryoStem

 

Life Stem Genetics announced today a strategic collaborative agreement with American CryoStem Corporation.

 

CRYO is a leading developer, marketer and global licensor of patented adipose tissue-based cellular technologies for the Regenerative and Personalized Medicine industries.

 

Adipose tissue is an anatomical term for loose connective tissue (fat) composed of adipocytes (cells). It is used in LIFS stem cell procedures and currently is extracted via liposuction each time a patient has a treatment.

Fight baldness using Stem Cells

Baldness is an undesirable condition that afflicts both men and women, many of which have family members with significant hair loss. According to Health Day News, a new study of stem cells in mice shows promise for future treatments for people who battle hair loss.

The study was conducted on the fatty skin layers of mice by researchers at Yale University. Specifically, adipose precursor cells were found to spur new hair growth in mice, according to Health Day News.

Stem cells are present in hair follicles, which help generate hair growth. Health Day News explains that these cells are still present
Read More…

SOUTH KOREA – Biotech Company Says It Will Cost Half to Clone Dogs

Cloning a Chow Chow will be easy and will also cost at least half of what it would cost to clone any other type of dog, announced a South Korean biotech company today while presenting new cloning technology.

But dog-owners – who pay 100,000 dollars or more to clone a pet – will still have to pay tens of thousands of dollars if they want to clone their beloved four-legged friends, and must be prepared for long waiting-lists, because most cloning at a commercial level involves dogs used for work, like police dogs used in airports.

The Rnl Bio company announced
Read More…

Adipose Stem Cell Heart Attack Trial Data Published

Adipose Stem Cell Heart Attack Trial Data Published in Journal of the American College of Cardiology; Cytori’s APOLLO Trial Demonstrated Safety & Feasibility and Improvements in Cardiac Function

Cytori Therapeutics announced today the publication of previously reported six-month outcomes from APOLLO, the Company’s European clinical trial evaluating adipose-derived stem and regenerative cells (ADRCs) in patients with acute myocardial infarction (heart attack or AMI), as Research Correspondence in the Journal of the American College of Cardiology. The APOLLO trial was a 14-patient, prospective, randomized, double-blind, placebo-controlled, feasibility trial (Phase I/IIA) evaluating autologous ADRCs extracted with the Company’s proprietary Celution® System for
Read More…

STEMCELL Technologies Applauds Feeder-Free Derivation of Human Induced Pluripotent Stem Cells

In a landmark paper, researchers at Stanford University have described a new way to derive human induced pluripotent stem cells (iPSCs) without the use of contaminating mouse feeder cells. Using adipose cells as the starting cell population and mTeSR1, a defined medium that allows the expansion of human embryonic and induced pluripotent stem cells without the use of feeders, the researchers were able to fully reprogram the cells to the pluripotent state.

mTeSR1 is a fully defined medium and is the most widely used feeder-independent method for culturing human pluripotent stem cells, with citations in more than 25 publications.

read
Read More…